{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-028740","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2022-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.686823+00:00","generated_at":"2026-06-21T07:52:33.239706+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"GeoVax appoints Dr. Jayne Morgan to Board; adopts 2023 Stock Incentive Plan","bullets":["Appointed Jayne Morgan, M.D. to Board effective Dec 7, 2022; brings expertise in COVID-19 management and health equity.","Morgan will serve on Nominating & Governance Committee and receive pro-rata director compensation.","Board approved 2023 Stock Incentive Plan, subject to shareholder approval, authorizing up to 3M shares of common stock.","2023 Plan replaces 2020 Stock Incentive Plan; no further grants under Prior Plan after effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-028740","json":"https://secwatch.observer/filing/0001437749-22-028740.json","markdown":"https://secwatch.observer/filing/0001437749-22-028740.md","text":"https://secwatch.observer/filing/0001437749-22-028740.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774922028740/0001437749-22-028740-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774922028740/govx20221207_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T07:52:33.239706+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a9acd237b","claim":"Jayne Morgan, M.D. was appointed as Director at GeoVax Labs, Inc..","evidence_excerpt":"On December 7, 2022, our Board of Directors (the “Board”) appointed Jayne Morgan, M.D. to the Board, effective as of December 7, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774922028740/0001437749-22-028740-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}